135 related articles for article (PubMed ID: 15162995)
21. Value of FDG PET in the management of NSCLC.
Ukena D; Hellwig D
Lung Cancer; 2004 Aug; 45 Suppl 2():S75-8. PubMed ID: 15552785
[TBL] [Abstract][Full Text] [Related]
22. Cardiac involvement from adenocarcinoma of the lung at diagnosis detected by (18)F-FDG-PET imaging.
Basu S; Alavi A
Hell J Nucl Med; 2008; 11(3):182. PubMed ID: 19081865
[No Abstract] [Full Text] [Related]
23. (18)F-FDG PET/CT scan in malignant priapism with diffuse pulmonary adenocarcinoma metastatic invasion of both corpus spongiosum and cavernosum.
Blanc E; Calais J; Cardot V; Mabille L
Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):588-9. PubMed ID: 24346413
[No Abstract] [Full Text] [Related]
24. [18F-FDG imaging by coincidence circuit SPECT with low-dose CT in preoperative assessment of pulmonary lesions].
Wang Q; Huang LL; Yue MG; Qin SL; Wang Y; Nie YX; Zhang CQ; Liang TJ; Zhao YM
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):924-7. PubMed ID: 17533745
[TBL] [Abstract][Full Text] [Related]
25. Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary?
Cho H; Lee HY; Kim J; Kim HK; Choi JY; Um SW; Lee KS
J Thorac Cardiovasc Surg; 2015 Sep; 150(3):514-20. PubMed ID: 26189165
[TBL] [Abstract][Full Text] [Related]
26. Standardized visual reading of F18-FDG-PET in patients with non-small cell lung cancer scheduled for preoperative thoracic lymph node staging.
Rogasch JM; Apostolova I; Steffen IG; Steinkrüger FL; Genseke P; Riedel S; Wertzel H; Achenbach HJ; Kalinski T; Schultz M; Schreiber J; Amthauer H; Furth C
Eur J Radiol; 2016 Aug; 85(8):1345-50. PubMed ID: 27423672
[TBL] [Abstract][Full Text] [Related]
27. Histological subtypes of lung adenocarcinoma have differential ¹⁸F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan.
Chiu CH; Yeh YC; Lin KH; Wu YC; Lee YC; Chou TY; Tsai CM
J Thorac Oncol; 2011 Oct; 6(10):1697-703. PubMed ID: 21869716
[TBL] [Abstract][Full Text] [Related]
28. Is 18F-3'-fluoro-3'-deoxy-L-thymidine useful for the staging and restaging of non-small cell lung cancer?
Cobben DC; Elsinga PH; Hoekstra HJ; Suurmeijer AJ; Vaalburg W; Maas B; Jager PL; Groen HM
J Nucl Med; 2004 Oct; 45(10):1677-82. PubMed ID: 15471832
[TBL] [Abstract][Full Text] [Related]
29. 1999 plenary session: Friday imaging symposium : evaluation of focal pulmonary abnormalities with FDG PET.
Patz EF
Radiographics; 2000; 20(4):1182-5. PubMed ID: 10903708
[No Abstract] [Full Text] [Related]
30. FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy.
Eschmann SM; Friedel G; Paulsen F; Budach W; Harer-Mouline C; Dohmen BM; Bares R
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):804-8. PubMed ID: 12029555
[TBL] [Abstract][Full Text] [Related]
31. 18F-FMT uptake seen within primary cancer on PET helps predict outcome of non-small cell lung cancer.
Kaira K; Oriuchi N; Shimizu K; Tominaga H; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Mori M; Endo K
J Nucl Med; 2009 Nov; 50(11):1770-6. PubMed ID: 19837768
[TBL] [Abstract][Full Text] [Related]
32. Patterns of abnormal FDG uptake by various histological types of non-small cell lung cancer at initial staging by PET.
Wong CY; Nuñez R; Bohdiewicz P; Welsh RJ; Chmielewski GW; Ravikrishnan KP; Hill JC; Pursel SE; Fink-Bennett D; Balon H; Dickinson C; Dworkin HJ
Eur J Nucl Med; 2001 Nov; 28(11):1702-5. PubMed ID: 11702114
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of Glut1 in lymphoid follicles correlates with false-positive (18)F-FDG PET results in lung cancer staging.
Chung JH; Cho KJ; Lee SS; Baek HJ; Park JH; Cheon GJ; Choi CW; Lim SM
J Nucl Med; 2004 Jun; 45(6):999-1003. PubMed ID: 15181136
[TBL] [Abstract][Full Text] [Related]
34. Diffusion-weighted magnetic resonance imaging in preoperative assessment of non-small cell lung cancer.
Nomori H; Cong Y; Abe M; Sugimura H; Kato Y
J Thorac Cardiovasc Surg; 2015 Apr; 149(4):991-6. PubMed ID: 25686657
[TBL] [Abstract][Full Text] [Related]
35. FDG PET: advantages for staging the mediastinum?
Franzius C
Lung Cancer; 2004 Aug; 45 Suppl 2():S69-74. PubMed ID: 15552784
[TBL] [Abstract][Full Text] [Related]
36. Lymph node staging in lung cancer using [18F]FDG-PET.
Halter G; Buck AK; Schirrmeister H; Aksoy E; Liewald F; Glatting G; Neumaier B; Mühling B; Nüssle-Kügele K; Hetzel M; Sunder-Plassmann L; Reske SN
Thorac Cardiovasc Surg; 2004 Apr; 52(2):96-101. PubMed ID: 15103582
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.
Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Uno K
Lung Cancer; 2004 Jul; 45(1):19-27. PubMed ID: 15196730
[TBL] [Abstract][Full Text] [Related]
38. The role of FDG-PET scan in staging patients with nonsmall cell carcinoma.
Cerfolio RJ; Ojha B; Bryant AS; Bass CS; Bartalucci AA; Mountz JM
Ann Thorac Surg; 2003 Sep; 76(3):861-6. PubMed ID: 12963217
[TBL] [Abstract][Full Text] [Related]
39. [Broncho-alveolar spread in a case of juvenile laryngeal papillomatosis (author's transl)].
Diard F; Traissac L; Elie G; Vigneaux F; Parsi B
J Radiol Electrol Med Nucl; 1977 Dec; 58(12):819-22. PubMed ID: 599521
[TBL] [Abstract][Full Text] [Related]
40. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Choi JY; Kwon OJ; Shim YM; Kim S
Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
